ENA RESPIRATORY
Who is ENA RESPIRATORY?
ENA Respiratory is a clinical-stage pharmaceutical company developing INNA-051, an intranasal innate immune modulator for the prevention of complications resulting from respiratory viral infections in at-risk populations, including older adults, those with co-morbidities (COPD, asthma, diabetes, and...See more
Industry & Specialities
Pharmaceuticals
Manufacturing
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2020 (6 years)
Address:
31 QUEEN STREET; MELBOURNE, VICTORIA 3000, AU
Employees by Department
- The Rest (3)
- Total (3)
Key Decision Makers
Narani Smyth
Senior Quality Assurance & Project Manager
Christophe Demaison
Managing Director and CEO
Chris Smith
Director
Insight
Signals
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
2employees
Senior
1employees
Non-managers
0employees
Financials
HIGH
spending power
Funding Status
Series B
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has ENA RESPIRATORY been operating for?
- What is the funding status of ENA RESPIRATORY?
- Where is ENA RESPIRATORY's headquarter?
- What ENA RESPIRATORY's spending power?
- Does ENA RESPIRATORY have a presence in the domain it operates in?